The Valley Desk

NCT03530683 · Interventional trial

A Clinical Trial to Learn About the Study Medicine Called Maplirpacept (PF-07901801), Alone and When Used in Combination With Other Medicines to Treat Participants With Advanced Hematological Malignancies, Including Lymphoma, Leukemia and Multiple Myeloma

Overall registry status Terminated

Phase 1

Conditions Acute Myeloid Leukemia, Diffuse Large B-Cell Lymphoma, Lymphoma, Multiple Myeloma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov